SE447449B - Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider - Google Patents

Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider

Info

Publication number
SE447449B
SE447449B SE8102456A SE8102456A SE447449B SE 447449 B SE447449 B SE 447449B SE 8102456 A SE8102456 A SE 8102456A SE 8102456 A SE8102456 A SE 8102456A SE 447449 B SE447449 B SE 447449B
Authority
SE
Sweden
Prior art keywords
choline
cdp
pharmaceutical composition
uci
phospholipids
Prior art date
Application number
SE8102456A
Other languages
English (en)
Swedish (sv)
Other versions
SE8102456L (sv
Inventor
E Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of SE8102456L publication Critical patent/SE8102456L/xx
Publication of SE447449B publication Critical patent/SE447449B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8102456A 1980-04-18 1981-04-15 Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider SE447449B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (2)

Publication Number Publication Date
SE8102456L SE8102456L (sv) 1981-10-19
SE447449B true SE447449B (sv) 1986-11-17

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102456A SE447449B (sv) 1980-04-18 1981-04-15 Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider

Country Status (15)

Country Link
US (1) US4386077A (es)
AT (1) AT376366B (es)
AU (1) AU544469B2 (es)
BE (1) BE890796A (es)
CH (1) CH652026A5 (es)
DE (1) DE3115080C2 (es)
DK (1) DK173081A (es)
ES (1) ES502080A0 (es)
FR (1) FR2480603B1 (es)
GB (1) GB2074445B (es)
IN (1) IN156105B (es)
IT (1) IT1207106B (es)
NL (1) NL8101899A (es)
SE (1) SE447449B (es)
ZA (1) ZA812600B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
CA2094217A1 (en) * 1992-04-17 1993-10-18 Yasutaka Igari Transmucosal therapeutic composition
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
WO1996027380A1 (en) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US8030294B2 (en) * 2000-03-16 2011-10-04 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US20060189566A1 (en) * 2003-02-26 2006-08-24 Miho Komatsu Muscle building agent and preventive or remedy for muscle weakening
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (en) * 2004-06-10 2010-09-22 Mclean Hospital Corp PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER
WO2006020703A1 (en) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (es) * 1969-08-04 1973-12-07
JPS4886869A (es) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
AU544469B2 (en) 1985-05-30
DK173081A (da) 1981-10-19
GB2074445B (en) 1983-09-07
ES8207184A1 (es) 1982-09-01
DE3115080A1 (de) 1982-02-25
ES502080A0 (es) 1982-09-01
IT1207106B (it) 1989-05-17
AT376366B (de) 1984-11-12
ZA812600B (en) 1982-04-28
FR2480603A1 (fr) 1981-10-23
SE8102456L (sv) 1981-10-19
FR2480603B1 (fr) 1985-07-12
GB2074445A (en) 1981-11-04
BE890796A (fr) 1982-02-15
IN156105B (es) 1985-05-18
ATA172081A (de) 1984-04-15
CH652026A5 (it) 1985-10-31
NL8101899A (nl) 1981-11-16
IT8048454A0 (it) 1980-04-18
AU6994581A (en) 1981-10-22
DE3115080C2 (de) 1986-10-16
US4386077A (en) 1983-05-31

Similar Documents

Publication Publication Date Title
SE447449B (sv) Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider
US5225404A (en) Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
MXPA03003401A (es) Formulacion liposomica de mitoxantrona.
JPS6310686B2 (es)
KR20190077476A (ko) 상글리페린 거대고리 유사체의 항암 화합물로서의 용도
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
JP2004517882A (ja) トリプトライドプロドラッグを使用する抗癌処置
GB2103485A (en) Liposomes containing antimony anti-leishmanaisis drugs
CN111346081A (zh) 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途
JPH07501534A (ja) ガンの治療のためのクレアチンホスフェート又はホスホエノールピルビン酸の使用
CA2351273C (en) Solution of n-[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
HU222888B1 (hu) Anilid vegyületek alkalmazása I típusú allergiás betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
JPH027575B2 (es)
CA2416600A1 (en) Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof
CN114848585A (zh) 一种改进的低毒高效原酸酯混溶物药用辅料、制备方法、包含该辅料的局部缓释给药制剂
MX2007005591A (es) Sintesis de analogos de cardiolipina y usos de los mismos.
Kim et al. The influence of homologs of riboflavin on the growth of Walker rat carcinoma 256
CA2912743A1 (en) Combination of ro5503781, capecitabine and oxaliplantin for cancer therapy
KR960015953B1 (ko) 피부에 축적하는 외용의 항바이러스성 약학적 조성물 및 그 제조방법
US4942172A (en) Method of curing hepatic disease
CN116159026B (zh) 一种熊果酸囊泡及其制备与应用
JPS632926A (ja) 安定な、注射可能な制吐性組成物
CN105412015B (zh) 甘草次酸修饰的恩替卡韦脂质体制剂及其制备方法
JPH08165236A (ja) 下痢の予防及び治療剤
JPH0720860B2 (ja) 制癌剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8102456-4

Effective date: 19910117

Format of ref document f/p: F